GlycoFlux™ Human GYS2 Overexpression HepG2 Cell Line (CAT#: GLJF-0925-JF641)

Description	GlycoFlux™ human GYS2 overexpression HepG2 cell line is a stable cell line designed to express glycogen synthase 2 (GYS2), the liver-specific isoform that catalyzes glucose addition from UDP-glucose to glycogen, representing a rate-limiting step in glycogen synthesis. Mutations cause glycogen storage disease type 0, characterized by fasting hypoglycemia and reduced glycogen stores. This system supports research on hepatic glucose homeostasis, metabolic disease modeling, and liver-targeted therapies.
Product Type	Overexpression Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:4~1:6
Cell Line	HepG2
Primary Disease	Hepatoblastoma
Lineage	Liver
Lineage Subtype	Hepatoblastoma

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	qPCR, Sanger Sequencing
Culture Medium	DMEM & FBS & Glutamine
Application	Mechanistic studies; Exploration of glycosylation and signaling pathways in cancer, metabolic, and immune-related diseases; Drug target validation and other functional assays.
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	GYS2
Full Name	Glycogen Synthase 2
Location	12p12.1
Gene ID	2998
Summary	This gene encodes liver glycogen synthase, which transfers glucose from UDP-glucose to glycogen, a rate-limiting step in glycogen synthesis. Mutations cause glycogen storage disease type 0.